Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

PCOS increases sexual pain and distress in infertile Iranian women.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

PCOS causes sexual dysfunction, needing comprehensive treatment.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Testosterone increases sexual behavior in female capuchin monkeys.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Stem cell treatment improved life quality and sexual function in women with hair loss.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The risks of testosterone implants in women outweigh the benefits.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

New treatments for male hypogonadism are effective and should be personalized.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Medicalization has shaped how society views health and gender roles over the past 200 years.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.